Forte Biosciences Publishes Clinical Trial 'Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study' To ClinicalTrials.Gov Site